A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...
Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...
The fight against obesity is one of the major challenges of 21st century medicine. This chronic disease, with its numerous ...
Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women. (HealthDay News) — Glucagon-like peptide-1 receptor agonists ...
Weight loss jabs could help reduce alcohol consumption in obese people by around two thirds, a new study suggests. Researchers believe the drugs, known as GLP-1 receptor agonists, could curb alcohol ...
The MarketWatch News Department was not involved in the creation of this content. Competitive Landscape of Obesity Therapeutics Market Enters High-Growth Phase, Fueled by GLP-1 Surge and Expanding ...
The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...
The GLP-1 agonists market stands at the forefront of innovation in metabolic and cardiovascular disease management. With the confluence of rising disease burden, expanding therapeutic indications, and ...
As the global pet obesity rate reaches alarming levels, Okava Pharmaceuticals, a San Francisco-based firm, launched a GLP-1-based pet weight management pilot study, MEOW-1 (Management of Overweight ...
† Deaths in LEAD-2: one in the run-in period, one after trial correction for hepatocellular carcinoma; deaths in LEAD-3: car accident. ‡ Only one out of five major hypoglycemic episodes required ...
Data were included for 262 adults with a body mass index greater than or equal to 27kg/m2 who were initiated on liraglutide or semaglutide. HealthDay News — Glucagon-like peptide-1 receptor agonists ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback